Kazia Therapeutics Limited Recorded Big Gain
Kazia Therapeutics Limited (KZIA:NASDAQ) jumped higher at $0.67, a gain of 248%. On Wed, Jul 10, 2024, KZIA:NASDAQ hit a New 2-Week High of $0.67. The stock appeared on our News Catalysts scanner on Wed, Jul 10, 2024 at 10:40 AM in the 'BIOTECH' category. From Wed, Jun 26, 2024, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Wed, Jul 10, 2024 at $1.08 with a volume of 430M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Kazia Therapeutics Limited (KZIA:NASDAQ), 248.02%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 110.23%
- Cingulate Inc. (CING:NASDAQ), 74.05%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 73.18%
- Ampco-Pittsburgh Corporation (AP:NYSE), 60.81%
- Longeveron Inc. (LGVN:NASDAQ), 58.54%
- uniQure N.V. (QURE:NASDAQ), 51.72%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 50.83%
- Phoenix New Media Limited (FENG:NYSE), 49.26%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 46.55%